About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The goal of the Shock, Organic Dysfunction and Resuscitation Research Group (SODIR) is comprehensive, innovative research into the areas of shock, acute respiratory failure, acute kidney failure, organic dysfunction, resuscitation and critical patient monitoring. In addition, the research group has a special interest in applying artificial intelligence as an instrument to find innovative solutions for critical patients.
PMID: 33380350 Journal: ARCHIVOS DE BRONCONEUMOLOGIA Year: 2021 Reference: Arch Bronconeumol. 2021 Apr;57 Suppl 2:1-2. doi: 10.1016/j.arbres.2020.10.021. Epub 2020 Nov 11. Impact factor: 4.872 Publication type: Editorial in national publication Authors: Torres, Antoni, Arguimbau, Maria, Bermejo-Martin, Jesus, Campo, Raquel, Ceccato, Adrian, Fernandez-Barat, Laia, Ferrer, Ricard, Jarillo, Natalia, Lorente-Balanza, Jose Angel, Menendez, Rosario et al. DOI: 10.1016/j.arbres.2020.10.021
PMID: 33583710 Journal: EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY Year: 2021 Reference: Eur J Vasc Endovasc Surg. 2021 Apr;61(4):628-634. doi: 10.1016/j.ejvs.2020.12.015. Epub 2020 Dec 23. Impact factor: 7.069 Publication type: Paper in international publication Authors: Ferrer, Ricard, de Nadal, Miriam, Monreal, Manel, Llagostera, Secundino, Ruiz-Rodriguez, Juan Carlos, Gil, Miquel, Martinez-Carnovale, Lucia, Bellmunt-Montoya, Sergi, Riera, Claudia, Gil, Daniel et al. DOI: 10.1016/j.ejvs.2020.12.015
PMID: 33856256 Journal: JOURNAL OF APPLIED PHYSIOLOGY Year: 2021 Reference: J Appl Physiol (1985). 2021 Jun 1;130(6):1660-1667. doi: 10.1152/japplphysiol.00614.2020. Epub 2021 Apr 15. Impact factor: 3.532 Publication type: Paper in international publication Authors: Garcia de Acilu, Marina, Pacheco, Andres, Santafe, Manel, Ramos, Francisco-Javier, Ruiz-Rodriguez, Juan C, Ferrer, Ricard, Roca, Oriol et al. DOI: 10.1152/japplphysiol.00614.2020
PMID: 33805755 Journal: Antibiotics-Basel Year: 2021 Reference: Antibiotics (Basel). 2021 Mar 13;10(3). pii: antibiotics10030299. doi: 10.3390/antibiotics10030299. Impact factor: 4.639 Publication type: Paper in international publication Authors: Krzanowski, Marcin, Czepiel, Jacek, Krutova, Marcela, Mizrahi, Assaf, Khanafer, Nagham, Enoch, David A, Patyi, Marta, Deptula, Aleksander, Agodi, Antonella, Nuvials, Xavier et al. DOI: 10.3390/antibiotics10030299
PMID: 31929536 Journal: PLoS One Year: 2020 Reference: PLoS One. 2020 Jan 13;15(1):e0226488. doi: 10.1371/journal.pone.0226488. eCollection 2020. Impact factor: 2.74 Publication type: Paper in international publication Authors: Berastegui, Cristina, Gomez-Olles, Susana, Mendoza-Valderrey, Alberto, Pereira-Veiga, Thais, Culebras, Mario, Monforte, Victor, Saez, Berta, Lopez-Meseguer, Manuel, Sintes-Permanyer, Helena, Ruiz de Miguel, Victoria et al. DOI: 10.1371/journal.pone.0226488
On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.
Hybrids VITA, developed together with Medical Simulator, reproduces different clinical scenarios for training on how to prevent, diagnose and treat possible complications of ECMO, which is a very complex technique.
Extracorporeal Cardiopulmonary Resuscitation (ECPR) offers therapeutic options for patients in whom conventional cardiopulmonary resuscitation techniques fail to restore the heartbeat.
